Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-8 of 8
Keywords: hormone
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2017) 131 (4): 329–342.
Published: 03 February 2017
... pharmacogenomic approaches. In the present review, we discuss the factors that may have contributed to the paucity of relevant studies summarizing available data. Hormonal fluctuations due to menstruation, pregnancy and menopause may have profound drug effects in women [ 84 ]. In fact, oral contraceptives...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2012) 122 (9): 429–437.
Published: 16 January 2012
... (plasma renin activity), aldosterone, AVP (arginine vasopressin), cortisol, endothelin-1, ANP (atrial natriuretic peptide), BNP (B-type natriuretic peptide), adrenaline and noradrenaline [ 23 ]. For each hormone, all samples from individual animals were measured in the same assay to avoid inter-assay...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2009) 117 (6): 209–228.
Published: 14 August 2009
... activity in approx. 80% of patients with advanced disease, but most tumours relapse within 2 years to an incurable hormone-resistant state. Even for patients with early disease at the time of diagnosis, a proportion of patients will unfortunately develop relapsed disease following radical therapy...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2008) 114 (10): 635–642.
Published: 14 April 2008
... in haemodynamics, hormonal profile and renal function than achieved by captopril alone. These results indicate that dual treatment with these two agents is beneficial. © The Authors Journal compilation © 2008 Biochemical Society 2008 Correspondence: Dr Miriam T. Rademaker (email miriam.rademaker...
Articles
Denzil GILL, Timothy SEIDLER, Richard W. TROUGHTON, Timothy G. YANDLE, Christopher M. FRAMPTON, Mark RICHARDS, John G. LAINCHBURY, Gary NICHOLLS
Journal:
Clinical Science
Clin Sci (Lond) (2004) 106 (2): 135–139.
Published: 01 February 2004
... 2003 15 9 2003 © 2004 The Biochemical Society 2004 creatine kinase hormone myocardial infarction myoglobin natriuretic peptide troponin Clinical Science (2004) 106, 135 139 (Printed in Great Britain) 135 Vigorous response in plasma N-terminal pro-brain natriuretic peptide (NT...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2002) 103 (s2002): 336S–339S.
Published: 01 September 2002
...Claudia HÖHNE; Roland C.E. FRANCIS; Gabriele KACZMARCZYK; Willehad BOEMKE This study compares the haemodynamic and hormonal responses during haemorrhage of conscious dogs pre-treated with an endothelin-A (ET-A) receptor inhibitor. The dogs were studied in two different randomized groups...
Articles
Atsuyuki WADA, Masato OHNISHI, Takayoshi TSUTAMOTO, Masanori FUJII, Takehiro MATSUMOTO, Takashi YAMAMOTO, Xinwen WANG, Masahiko KINOSHITA
Journal:
Clinical Science
Clin Sci (Lond) (2002) 103 (s2002): 254S–257S.
Published: 01 September 2002
... with the development of congestive heart failure (CHF). The selective enzymic inhibition of ET-1 formation thus seems to be a very important target in the prevention of CHF. We evaluated the chronic effects of a specific ECE inhibitor, FR901533 (0.3mg·kg -1 ·h -1 , n = 5) on cardiac, hormonal, and body fluid balance...
Articles
Maria J. PASCUAL, Maria A. SERRANO, Mohamad Y. EL-MIR, Rocio I.R. MACIAS, Felipe JIMÉNEZ, Jose J.G. MARIN
Journal:
Clinical Science
Clin Sci (Lond) (2002) 102 (5): 587–593.
Published: 22 April 2002
... in progesterone metabolism may be involved in the aetiology of ICP. Correspondence: Dr Jose J.G. Marin (e-mail [email protected] ). 3 9 2001 21 10 2001 28 1 2001 The Biochemical Society and the Medical Research Society © 2002 2002 bile acid cholestasis gestation hormone...